Peter Diamandis

Peter Diamandis is the Co-founder and General Partner of BOLD Capital Partners, a venture capital fund managing approximately $600 million in assets to invest in early-stage technology companies. Throughout his career, he has launched more than 25 companies across the aerospace, biotechnology, and education sectors, including co-founding notable ventures like Human Longevity Inc., Celularity, and Vaxxinity. He also serves as the Founder and Executive Chairman of the XPRIZE Foundation, an organization that has launched over $600 million in global incentive competitions, and is the Executive Founder of Singularity University. Diamandis earned undergraduate and graduate degrees in Molecular Genetics and Aerospace Engineering from the Massachusetts Institute of Technology, followed by a medical degree from Harvard Medical School. His current investment and entrepreneurial focus centers on leveraging exponential technologies to advance the commercial space industry, biotechnology, and human longevity.